The Asia-Pacific market includes Japan, South Korea, and Australia. In 2008, the combined Asia-Pacific market for dental bone graft substitutes (BGS) and other biomaterials was valued at nearly US$62.5 million. The economic recession, beginning in 2008, led to a decline in the unit growth ate of the dental bone grafts and biomaterials market, especially for South Korea and Japan. Autografts account for an unusually large percentage of dental BGS materials used in the Asia-Pacific region because allograft and xenograft products are not approved for use in Japan. In addition, non-resorbable synthetic membranes are far more popular in Asia-Pacific than in Europe or the U.S. By 2015, the combined market for dental BGS and other biomaterials is expected to reach approximately US$160 million.
The market for dental bone graft substitutes (BGS) consists of
Demineralized bone matrix
The market for these products is driven by the number of dental bone grafting procedures performed. This report also covers the market for dental membranes, which is linked to the market for bone graft substitutes.
This report provides a comprehensive and detailed analysis of market revenues by bone graft substitute type, market forecasts through 2016, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.